First Trust Advisors’s Genomic Health, Inc. GHDX Stock Holding History

First Trust Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,518	Closed	-$646K	–	2515
2019 Q3	$646K	Sell	9,518 -28,741	-75%	-$1.97M	﹤0.01%	2036
2019 Q2	$2.23M	Sell	38,259 -12,635	-25%	-$748K	﹤0.01%	1485
2019 Q1	$3.56M	Sell	50,894 -4,066	-7%	-$301K	0.01%	1227
2018 Q4	$3.54M	Sell	54,960 -32,075	-37%	-$2.25M	0.01%	1156
2018 Q3	$6.11M	Buy	87,035 +74,611	+601%	+$4.36M	0.01%	1028
2018 Q2	$626K	Sell	12,424 -21,266	-63%	-$844K	﹤0.01%	2079
2018 Q1	$1.05M	Buy	33,690 +26,684	+381%	+$885K	﹤0.01%	1768
2017 Q4	$240K	Sell	7,006 -28,037	-80%	-$894K	﹤0.01%	2286
2017 Q3	$1.13M	Buy	35,043 +1,094	+3%	+$34.5K	﹤0.01%	1805
2017 Q2	$1.1M	Buy	33,949 +11,885	+54%	+$376K	﹤0.01%	1800
2017 Q1	$695K	Sell	22,064 -22,961	-51%	-$679K	﹤0.01%	1964
2016 Q4	$1.32M	Buy	45,025 +31,247	+227%	+$953K	﹤0.01%	1692
2016 Q3	$398K	Buy	+13,778	New	+$384K	﹤0.01%	2057

First Trust Advisors's GHDX Position: Q4 2019 in Review

First Trust Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 9,518 shares — an estimated $646K sold.

First Trust Advisors first reported a position in GHDX in Q3 2016 and held it in 13 quarters. The position peaked at $6.11M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

First Trust Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
First Trust Advisors sold 9,518 Genomic Health, Inc. shares in Q4 2019, an estimated $646K.
First Trust Advisors first reported a position in Genomic Health, Inc. in Q3 2016 and held it in 13 quarters.
First Trust Advisors's Genomic Health, Inc. position peaked at $6.11M in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on First Trust Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.